TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 4 | 17 | 39 | 0 | 0 | 15 |
| P | %wins | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/5/22 17:00 | 6/30/22 | TARA | Protara Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Beshar Luke M | NY | D | P | 31 | 3.10 | 0 | 10 | 5 | 198 | D | ||||||||||||||||
3/16/22 16:37 | 3/14/22 | TARA | Protara Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Beshar Luke M | NY | D | P | 43 | 4.25 | 0 | 10 | 6 | 188 | D | ||||||||||||||||
3/14/22 16:37 | 3/10/22 | TARA | Protara Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Beshar Luke M | NY | D | P | 45 | 4.46 | 0 | 10 | 6 | 178 | D | ||||||||||||||||
11/10/11 11:53 | 11/9/11 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beshar Luke M | NJ | O | SVP,CFO | P | 107 | 5.36 | 13 | 20 | 758 | 23 | D | 76 | -17 | -48 | -25 | -19 | -21 | 3 | -5 | 1 | 4 | 17 | 39 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |